This section will contain updates from the pain industry.

Could a Blood Test Measure Your Pain and Mood? One Startup Believes It Can

A medical startup called MindX Sciences are working to develop a blood test using biomarker technology for those conditions that have previously been so hard to measure, including pain.   Full story.
Topics:

FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

Erchonia Corporation announces another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category in January 2002. That year, the FDA issued its first 510(k) market clearance for any low-level laser based on Erchonia's clinical trial for chronic neck and shoulder pain.

Continue reading
Topics:

First Utahns Treated in Nationwide FDA-Allowed Clinical Study of Locally Developed Cell Therapy for Chronic Low Back Pain

A clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first Utahns have been treated in its nationwide clinical study of IDCT, a locally developed injectable disc cell therapy for degenerative disc disease (DDD).

Continue reading
Topics:

FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality ® (galcanezumab-gnlm) injection (300 mg) for the treatment of episodic cluster headache in adults.  Full s...
Continue reading
Topics:

Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics

Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain. CNTX-0290, is a novel, small molecule somatostatin receptor type 4 (SSTR4) agonist that is currently being studied in Phase 1 clinical testing as a potential non-opioid treatment for chronic pain conditions. 

Continue reading
Topics:

FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra®, utilizing Remote Electrical Neuromodulation for the acute treatment of migraine. 

Continue reading

Kailo Labs Launches the World’s First Nanotech Bio-Antenna for Pain Relief

Kailo Labs, an Utah-based nanotech startup, has launched the world's first nanotechnology-based bio-antenna for easy pain relief.  Full story.  
Topics:

Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic's Evolve(SM) Workflow with Spinal Cord Stimulation

Medtronic today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation (SCS) utilizing the EvolveSM workflow

Continue reading
Topics:
SCS

Join AAPM in Thanking the Following Companies for their Support

The AAPM Corporate Relations Council (CRC) is a distinguished community of healthcare professionals with a sustained interest in pain disorders and pain management. Thanks to these companies for supporting the Academy's goals and mission.

Continue reading

Aegis Science Corporation Presents Corporate Showcase at AAPM35

View the 30-minute webinar : Are drug interactions harming your patients? Enhance DDI identification and patient care with Interact Rx™ Presented by Josh Schrecker, Pharm.D., Clinical Scientist, Healthcare Services, Aegi...
Continue reading
Topics:
DDI

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More